Brussels, 09/09/2005 (Agence Europe) - The European Federation of Pharmaceuticals Industries and Associations (EFPIA) welcomed the vote by the European Parliament on the dossier on medicines for paediatric use (EUROPE 9020), which was not quite so well received by the producers of generic drugs. In a press release, the association representing them (EGA) regretted the adoption of an incentive set at six months.
Speaking to the press in Strasbourg on Wednesday, Françoise Grossetête pointed...